The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study

References

• Arnold AC, Costa RM, Dumitrascu OM. The spectrum of optic disc ischemia in patients younger than 50 years (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2013;111:93–118.
   Google Scholar
• Arda H, Birer S, Aksu M, Ismailogullari S, Karakucuk S, Mirza E, et al. Obstructive sleep apnoea prevalence in non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2013;97(2):206–209.
   PubMed Web of Science ®Google Scholar
• Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003;23(2):157–163.
   PubMed Web of Science ®Google Scholar
• Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993;116(6):759–764.
   PubMed Web of Science ®Google Scholar
• Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 2010;55(1):47–63.
   PubMed Web of Science ®Google Scholar
• Parsa CF, Hoyt WF. Nonarteritic anterior ischemic optic neuropathy (NAION): a misnomer. Rearranging pieces of a puzzle to reveal a nonischemic papillopathy caused by vitreous separation. Ophthalmology 2015;122(3):439–442.
   Google Scholar
• Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123(2):212–217.
   PubMed Web of Science ®Google Scholar
• Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003;44(10):4153–4162.
   PubMed Web of Science ®Google Scholar
• Levin LA, Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114(4):488–491.
   PubMedGoogle Scholar
• Zhang C, Guo Y, Slater BJ, Miller NR, Bernstein SL. Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION). Exp Eye Res 2010;91(2):286–292.
   PubMed Web of Science ®Google Scholar
• Lee AG, Biousse V. Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol 2010;30(2):193–198.
   PubMed Web of Science ®Google Scholar
• Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) 2015;29(1):65–79.
   PubMed Web of Science ®Google Scholar
• Grasso G, Sfacteria A, Meli F, Passalacqua M, Fodale V, Buemi M, et al. The role of erythropoietin in neuroprotection: therapeutic perspectives. Drug News Perspect 2007;20(5):315–320.
   PubMedGoogle Scholar
• Rex TS, Wong Y, Kodali K, Merry S. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res 2009;89(5):735–740.
   PubMed Web of Science ®Google Scholar
• Falavarjani KG, Modarres M. Erythropoietin; a novel neuroprotective agent for ocular disorders. J Ophthalmic Vis Res 2011;6(1):76–77.
   PubMedGoogle Scholar
• Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008;49(2):732–742.
   PubMed Web of Science ®Google Scholar
• Levin LA. Axonal loss and neuroprotection in optic neuropathies. Can J Ophthalmol 2007;42(3):403–408.
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, et al. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Graefes Arch Clin Exp Ophthalmol 2011;249(5):731–736.
   PubMed Web of Science ®Google Scholar
• Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. J Neuroophthalmol 2012;32(4):325–328.
   PubMed Web of Science ®Google Scholar
• Diem R, Molnar F, Beisse F, Gross N, Druschler K, Heinrich SP, et al. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol. BMJ Open 2016;6(3):e010956.
   PubMed Web of Science ®Google Scholar
• Modarres M, Falavarjani KG, Nazari H, Sanjari MS, Aghamohammadi F, Homaii M, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2011;95(7):992–995.
   PubMed Web of Science ®Google Scholar
• Abri Aghdam K, Soltan Sanjari M, Ghasemi Falavarjani K. Erythropoietin in ophthalmology: A literature review. J Curr Ophthalmol 2016;28(1):5–11.
   PubMedGoogle Scholar
• Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008;115(2):298–305.e2.
   PubMed Web of Science ®Google Scholar
• Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1994;14(2):66–69.
   PubMed Web of Science ®Google Scholar
• Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist 2008;14(6):341–354.
   PubMed Web of Science ®Google Scholar
• Atkins EJ. Nonarteritic anterior ischemic optic neuropathy. Curr Treat Options Neurol 2011;13(1):92–100.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008;246(7):1029–1046.
   PubMed Web of Science ®Google Scholar
• Foulds WS. Visual disturbances in systemic disorders. Optic neuropathy and systemic disease. Trans Ophthalmol Soc UK 1970;89:125–146.
   PubMedGoogle Scholar
• Kinori M, Ben-Bassat I, Wasserzug Y, Chetrit A, Huna-Baron R. Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy - retrospective analysis. BMC Ophthalmol 2014;14:62.
   PubMed Web of Science ®Google Scholar
• Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res 2004;1000(1–2):19–31.
   PubMed Web of Science ®Google Scholar
• Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 2004;63(2):208–216.
   PubMed Web of Science ®Google Scholar
• Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005;293(1):90–95.
   PubMed Web of Science ®Google Scholar
• Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009;6(1):108–127.
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Roth KA. Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications. Curr Drug Targets CNS Neurol Disord 2005;4(1):25–39.
   PubMedGoogle Scholar
• Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45(5):1514–1522.
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004;11 Suppl 1:S37–S44.
   PubMed Web of Science ®Google Scholar
• Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002;99(16):10659–10664.
   PubMed Web of Science ®Google Scholar
• Schepens CL. Clinical aspects of pathologic changes in the vitreous body. Am J Ophthalmol 1954;38( 1:2):8–21.
   Google Scholar
• Sanjari MS, Falavarjani KG, Parvaresh M-M, Modarreszadeh M, Naseripour M, Hashemi M, et al. Vitreopapillary traction in nonarteritic anterior ischemic optic neuropathy. J Ophthalmic Vis Res 2006;1(2).
   Google Scholar
• Lee MS, Foroozan R, Kosmorsky GS. Posterior vitreous detachment in AION. Ophthalmology 2009;116(3):597–.e1.
   Google Scholar
• Modarres M, Sanjari MS, Falavarjani KG. Vitrectomy and release of presumed epipapillary vitreous traction for treatment of nonarteritic anterior ischemic optic neuropathy associated with partial posterior vitreous detachment. Ophthalmology 2007;114(2):340–344.
   PubMed Web of Science ®Google Scholar
• Lee GH, Stanford MP, Shariati MA, Ma JH, Liao YJ. Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2014;55(11):7111–7118.
   PubMed Web of Science ®Google Scholar
• Diem R, Sattler MB, Merkler D, Demmer I, Maier K, Stadelmann C, et al. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 2005;128(Pt 2):375–385.
   PubMed Web of Science ®Google Scholar